Your browser doesn't support javascript.
loading
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Marina, Neyssa M; Smeland, Sigbjørn; Bielack, Stefan S; Bernstein, Mark; Jovic, Gordana; Krailo, Mark D; Hook, Jane M; Arndt, Carola; van den Berg, Henk; Brennan, Bernadette; Brichard, Bénédicte; Brown, Ken L B; Butterfass-Bahloul, Trude; Calaminus, Gabriele; Daldrup-Link, Heike E; Eriksson, Mikael; Gebhardt, Mark C; Gelderblom, Hans; Gerss, Joachim; Goldsby, Robert; Goorin, Allen; Gorlick, Richard; Grier, Holcombe E; Hale, Juliet P; Hall, Kirsten Sundby; Hardes, Jendrik; Hawkins, Douglas S; Helmke, Knut; Hogendoorn, Pancras C W; Isakoff, Michael S; Janeway, Katherine A; Jürgens, Heribert; Kager, Leo; Kühne, Thomas; Lau, Ching C; Leavey, Patrick J; Lessnick, Stephen L; Mascarenhas, Leo; Meyers, Paul A; Mottl, Hubert; Nathrath, Michaela; Papai, Zsuzsanna; Randall, R Lor; Reichardt, Peter; Renard, Marleen; Safwat, Akmal Ahmed; Schwartz, Cindy L; Stevens, Michael C G; Strauss, Sandra J; Teot, Lisa.
Afiliação
  • Marina NM; Stanford University School of Medicine and Lucile Packard Children's Hospital, Palo Alto, CA, USA.
  • Smeland S; Oslo University Hospital, Division of Cancer Medicine and Scandinavian Sarcoma Group, University of Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Norway.
  • Bielack SS; Klinikum Stuttgart-Olgahospital, Cooperative Osteosarcoma Study Group (COSS), Stuttgart, Germany.
  • Bernstein M; IWK Health Center, Dalhousie University, Halifax, NS, Canada.
  • Jovic G; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Krailo MD; Department of Preventive Medicine, Keck Medical Canter at the University of Southern California, Los Angeles CA, USA; Children's Oncology Group, Arcadia, CA, USA.
  • Hook JM; Medical Research Council Clinical Trials Unit at University College London, London, UK; Clinical Trials Research Unit, Institute of Clinical Trials Research, University of Leeds, Leeds, UK; St James' Institute of Oncology, Leeds, UK.
  • Arndt C; Division of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
  • van den Berg H; Emma Children Hospital/Academic Medical Centre, Amsterdam, Netherlands.
  • Brennan B; Royal Manchester Children's Hospital, Manchester, UK.
  • Brichard B; Department of Pediatric Hematology/Oncology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Brown KLB; Department of Orthopaedics, University of British Columbia, Vancouver, BC, Canada.
  • Butterfass-Bahloul T; Centre for Clinical Trials, University Hospital Muenster, Muenster, Germany.
  • Calaminus G; Pädiatrische Hämatologie und Onkologie, Universitätsklinikum Bonn, Bonn, Germany.
  • Daldrup-Link HE; Department of Radiology, Stanford University and Lucile Packard Children's Hospital, Palo Alto, CA, USA.
  • Eriksson M; Skane University Hospital and Lund University, Lund, Sweden.
  • Gebhardt MC; Department of Surgery, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gelderblom H; Leiden University Medical Center, Leiden, Netherlands.
  • Gerss J; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Goldsby R; UCSF Medical Center-Mission Bay, Pediatric Oncology, San Francisco, CA, USA.
  • Goorin A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gorlick R; Division of Pediatric Hematology-Oncology, The Children's Hospital at Montefiore, Bronx, NY, USA.
  • Grier HE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hale JP; Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
  • Hall KS; Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Scandinavian Sarcoma Group, Oslo, Norway.
  • Hardes J; Klinik für Allgemeine Orthopädie und Tumororthopädie, University of Muenster, Muenster, Germany.
  • Hawkins DS; Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.
  • Helmke K; Abt Pädiatrische Radiologie, AKK Altonaer Kinderkrankenhaus, Hamburg, Germany.
  • Hogendoorn PCW; Leiden University Medical Center, Leiden, Netherlands.
  • Isakoff MS; Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, CT, USA.
  • Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jürgens H; Pädiatrische Hämatologie und Onkologie, University of Muenster, Muenster, Germany.
  • Kager L; Department of Pediatrics, St Anna Children's Hospital, Medical University Vienna, Vienna, Austria.
  • Kühne T; University Children's Hospital Basel, Basel, Switzerland.
  • Lau CC; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Leavey PJ; Department of Pediatrics, UT Southwestern and Children's Medical Center, Dallas, TX, USA.
  • Lessnick SL; Center for Childhood Cancer and Blood Disorders, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA.
  • Mascarenhas L; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Meyers PA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mottl H; University Hospital Motol, Pediatric Hematology/Oncology, Prague, Czech Republic.
  • Nathrath M; Clinical Cooperation Group Osteosarcoma, Pediatric Oncology Center, Department of Pediatrics, Technical University Munich, Munich, Germany; Department of Pediatric Oncology, Klinikum Kassel, Kassel, Germany.
  • Papai Z; National Medical Center, Oncology Department, Budapest, Hungary.
  • Randall RL; Primary Childrens Hospital, The University of Utah, Salt Lake City, UT, USA.
  • Reichardt P; HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie, Berlin, Germany.
  • Renard M; Department of Pediatric Hemato-oncology, University Hospital Leuven, Leuven, Belgium.
  • Safwat AA; Aarhus University Hospital, Aarhus C, Denmark.
  • Schwartz CL; Division of Pediatrics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA.
  • Stevens MCG; Bristol Royal Hospital for Children, Bristol, UK.
  • Strauss SJ; Department of Oncology, University College Hospital, London, UK.
  • Teot L; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
Lancet Oncol ; 17(10): 1396-1408, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27569442
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos